#GlobalNews: « Canada expands blood pressure drug recall to include more valsartan medications – National » #Toronto #Montreal #Calgary #Ottawa #Canada


Health Canada has recalled eight extra blood strain medicines that comprise the ingredient valsartan, resulting from doable impurities linked to an elevated threat of most cancers.

Health Canada introduced the expanded recall on Sunday, after testing recognized traces of the impurity in merchandise from Teva Canada. Teva is among the many high 5 Canadian pharmaceutical firms in annual gross sales.

Valsartan is used to deal with sufferers with blood strain points, in addition to those that have lately suffered a coronary heart assault or coronary heart failure.

Blood strain medicines recalled resulting from contamination with potential carcinogen

The affected treatment might comprise traces of N-nitrosodimethylamine (NDMA), a “probable human carcinogen” that might improve the danger of most cancers by way of long-term publicity above acceptable ranges, Health Canada says.

Anyone who takes valsartan is inspired to proceed doing so, except instructed in any other case by a health-care supplier, Health Canada says. Individuals utilizing a recalled product are urged to get in contact with their physician to debate remedy choices, as there are nonetheless plenty of valsartan merchandise not affected by the recall.

High blood strain is a ‘silent killer’ — however many nonetheless don’t know the dangers

The recalled medicine have been provided by Zhejiang Huahai Pharmaceuticals, a Chinese firm that ships valsartan to greater than a dozen international locations.

Health Canada says the impurities have been possible launched when the manufacturing course of was modified in 2012, though some Canadian firms might have been utilizing the affected merchandise for much less time.

The U.S. Food and Drug Administration (FDA) expanded its personal recall of valsartan medicine earlier this month to incorporate merchandise made at a facility in India. The FDA mentioned the Indian facility was producing valsartan “using a process similar to Zhejiang Huahai Pharmaceuticals.”

WATCH BELOW: Tips to stop hypertension

Officials at Health Canada say they’ve been in contact will all Canadian valsartan suppliers, and that a number of merchandise stay unaffected by the impurity problem.

A full listing of unaffected merchandise might be discovered on Health Canada’s web site.

The newly-recalled Teva Canada medicine are listed under. For a full listing of recalled valsartan medicines, go to Health Canada’s web site:

  • TEVA-VALSARTAN/HCTZ TABLETS 80/12.5 MG, DIN 02356996, LOT 35211136A
  • TEVA-VALSARTAN/HCTZ TABLETS 160/12.5 MG, DIN 02357003, LOT 35211335A
  • TEVA-VALSARTAN/HCTZ TABLETS 160/25 MG, DIN 02357003, 35211844R
  • TEVA-VALSARTAN/HCTZ TABLETS 160/25 MG, DIN 02357011, 35210937R
  • TEVA-VALSARTAN/HCTZ TABLETS 160/25 MG, DIN 02357011, LOT 35210938R
  • TEVA-VALSARTAN/HCTZ TABLETS 160/25 MG, DIN 02357011, LOT 35210939R
  • TEVA-VALSARTAN/HCTZ TABLETS 160/25 MG, DIN 02357011, LOT 35210940R
  • TEVA-VALSARTAN/HCTZ TABLETS 320/12.5 MG, DIN 02357038, LOT 35211546R

© 2018 Global News, a division of Corus Entertainment Inc.

Note: « Previously Published on: 2018-08-20 11:26:34, as ‘Canada expands blood strain drug recall to incorporate extra valsartan medicines – National’ on GLOBALNEWS CANADA. Here is a supply hyperlink for the Article’s Image(s) and Content ».

Global News Canada

Copyright © 2017 Global News, a division of Corus Entertainment Inc. Corus News. All rights reserved. Distributed by PressOcean Global Media (pressocean.com). Contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material... Articles and commentaries that identify PressOcean.com as the publisher are produced or commissioned by PressOcean. To address comments or complaints, please Contact us.


No comments!

There are no comments yet, but you can be first to comment this article.

Leave reply

Seuls les utilisateurs enregistrés peuvent laisser un commentaire.